Patients News | pharmaphorum

News

CSL, BrightInsight launch Hemgenix companion app

CSL Behring's recently approved gene therapy for haemophilia B Hemgenix has joined the swelling ranks of new medicines that are bundled with a companion app to support the

News

NICE changes its mind on Lilly's Mounjaro for diabetes

Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiven

News

UK women cleared to sue Bayer over Essure contraceptive

Women in the UK who claim to have suffered harm after being fitted with Bayer's Essure contraceptive device have been cleared to pursue legal action against the company.

News

Two Babylon Health divisions have been sold to eMed

Babylon Health's administrators have confirmed that two of the company's divisions have been sold to US digital health business eMed, after an earlier bid to merge the gro

News

Wegovy finally reaches the UK, in 'limited' quantities

Novo Nordisk's sought-after obesity therapy Wegovy has finally reached the UK and can be prescribed by NHS weight management services – but supplies are being carefully co

News

Nursa's $80m raise leads recent digital health financings

A steady stream of fundraising in the digital health category this month was headed by a $80 million second round by Nursa, a digital platform designed to prevent hospital

CSL, BrightInsight launch Hemgenix companion app

NICE changes its mind on Lilly's Mounjaro for diabetes

UK women cleared to sue Bayer over Essure contraceptive

Two Babylon Health divisions have been sold to eMed

Wegovy finally reaches the UK, in 'limited' quantities

Nursa's $80m raise leads recent digital health financings

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks